Swedish Orphan Biovitrum AB - Sobi
- A04 - Antieméticos y antinauseosos
- AKYNZEO capsule, hard 300 mg+0.5 mg
- AKYNZEO powder for solution for infusion 235 mg+0.25 mg
- ALOXI capsule, soft 500 µg
- ALOXI solution for injection 250 µg/5 ml
- B02 - Antihemorrágicos
- ALPROLIX powder and solvent for solution for injection 1 000 IU
- ALPROLIX powder and solvent for solution for injection 2 000 IU
- ALPROLIX powder and solvent for solution for injection 250 IU
- ALPROLIX powder and solvent for solution for injection 3 000 IU
- ALPROLIX powder and solvent for solution for injection 500 IU
- DOPTELET film-coated tablet 20 mg
- ELOCTA powder and solvent for solution for infusion 4 000 IU
- ELOCTA powder and solvent for solution for infusion 5 000 IU
- ELOCTA powder and solvent for solution for infusion 6 000 IU
- ELOCTA powder and solvent for solution for injection 1 000 IU
- ELOCTA powder and solvent for solution for injection 1 500 IU
- ELOCTA powder and solvent for solution for injection 2 000 IU
- ELOCTA powder and solvent for solution for injection 250 IU
- ELOCTA powder and solvent for solution for injection 3 000 IU
- ELOCTA powder and solvent for solution for injection 500 IU
- ELOCTA powder and solvent for solution for injection 750 IU
- C10 - Agentes modificadores de los lípidos
- WAYLIVRA I FÖRFYLLD SPRUTA solution for injection 285 mg/1.5 ml
- H02 - Corticosteroides para uso sistémico
- BETAPRED solution for injection 20 mg/5 ml
- BETAPRED solution for injection 4 mg/1 ml
- BETAPRED tablet 0.5 mg
- L04 - Inmunosupresores
- KINERET I FÖRFYLLD SPRUTA solution for injection 100 mg/0.67 ml
- N07 - Otros fármacos activos sobre el sistema nervioso
- TEGSEDI I FÖRFYLLD SPRUTA solution for injection 284 mg